Gây mê trong phẫu thuật ghép thận ở bệnh nhân bệnh hồng cầu hình liềm

Serjeant GR. Sickle Cell Disease, 1st ed. New York: Oxford University Press, 1985. Weatherall DJ. Disorders of the synthesis and function of haemoglobin. In: Weatherall DJ, Ledingham JGG, Warell DA (Eds.). Oxford Textbook of Medicine, 2nd ed. Oxford: Oxford University Press, 1987; 19: 108–30. Abdalla SH, Weatherall DJ. Haematological problems. In: Manson-Bahr PEC, Bell DR (Eds.). Manson’s Tropical Diseases. 19th ed. London: Balliere, Tyndall 1987: 942–86. Esseltine DW, Baxter MRN, Bevan JC. Sickle cell states and the anaesthetist. Can J Anaesth 1988;35: 385–403. Kunz HW, Mellin GW, Cheung MW, Pratt EL. Impairment of urinary concentration in sickle cell anaemia. Am J Dis Child 1953; 86: 512. McCrory WW, Goren N, Gornfield D. Demonstration of impairment of urinary concentration ability or “Pitressin Resistance” in children with sickle-cell anaemia. Am J Dis Child 1953; 86: 512–3. McCoy RC. Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab Invest 1969; 21: 85–95. Buckalew VM, Someren A. Renal manifestations of sickle cell disease. Arch Int Med 1974; 133: 660–9. Alleyne GAO, Statius van Eps LW, Addae SK, Nicholson GD, Schouten H. The kidney in sickle cell anaemia. Kidney Int 1975; 7: 371–9. De Jong PE, Statius van Eps LW. Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int 1985; 27:711–7. Strauss J, Zilleruelo G, Abitbol C. The kidney and haemoglobin S. Nephron 1986; 43: 241–5. Pearson HA. The kidney, hepatobiliary system and spleen in sickle cell anaemia. Ann N Y Acad Sci 1989; 565: 120–5. Houston JC, Joiner CL, Trounce JR. Diseases of the kidney. In: A Short Textbook of Medicine, 7th ed. London: Hodder and Stoughton, 1982; 448–97. Chartterjee SN. National study in natural history of renal allografts in sickle cell disease or trait: a second report. Transplant Proc 1987; 19: 33–5. Oduro KA, Searle JF. Anaesthesia in sickle cell states: a plea for simplicity. Br Med J 1972; 2: 596–8. Gilbertson AA. Anaesthesia in West African patients with sickle anaemia, haemoglobin SC disease and sickle cell trait. Br J Anaesth 1965; 37: 614–21. Morgan AG, Serjeant GR. Renal function in patients over 40 with sickle cell anaemia. Br Med J 1981; 282: 1181–3. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle cell disease in Jamaica. Br Med J 1982; 285: 633–5. De Fronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR. Impaired renal tubular potassium secretion in sickle cell disease. Ann Int Med 1979; 90: 310–6. Battle D, Itsarayoungyuen K, Arruda JAL, Kurtzman NA. Hyperkalaemic hyperchloraemic metabolic acidosis in sickle cell haemoglobinopathies. Am J Med 1982; 72: 188–92. Thomas R, Holdbrook T. Sickle cell disease: ways to reduce morbidity and mortality. Postgrad Med 1987; 81: 265–80. Cruz IA, Hosten AO, Dillard MG, Castro OL. Advanced renal failure in patients with sickle cell anaemia: clinical course and prognosis. J Natl Med Ass 1982; 74: 1103–9. Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM. Nephropathy associated with sickle cell anaemia. An autologous immune complex nephritis. II. Clinicopathological study of seven patients. Am J Med 1975; 59: 512–3. Bakir AA, Hathiwala SC, Ainis H et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy. Am J Nephrol 1987; 7: 110–5. Davies S, Henthorn J, Brozovic M. Iron deficiency in sickle cell anaemia. J Clin Pathol 1983; 36: 1012–5. Gilbertson AA. The management of anaesthesia in sickle cell states. Proc R Soc Med 1967; 60: 631–5. Oduro KA. Anaesthesia in Ghana: a review with particular reference to indigenous medical conditions. Anaesthesia 1969; 3: 307–16. Miner DJ, Jorkasky DK, Perloff LJ, Grossman RA, Tomaszewski JE. Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 1987; 10: 306–13. Barber WH, Deierhoi MH, Julian BA et al. Renal transplantation in sickle cell anaemia and sickle cell disease. Clinical Transplantation 1987; 1: 169–75. Spector D, Zachary JB, Steriof S, Millan J. Painful crises following renal transplantation in sickle cell anemia. Am J Med 1978; 64: 835–9. Gonzalez-Carrillo M, Rudje CJ, Parsons V, Bewick M, White JM. Renal transplantation in sickle cell disease. Clin Nephrol 1982; 18: 209–10. Donnelly PK, Edmunds ME, O’Reilly K. Renal transplantation in sickle cell disease. (Letter) Lancet 1988; 2: 229. Sear JW. Anaesthesia in renal transplantation. In: Morris P (Ed.). Kidney Transplantation, Principles and Practice, 3rd ed. Philadelphia: Saunders, 1988: 235–61. Dean JD, Schechter AN. Sickle cell anaemia: molecular and cellular bases of therapeutic approaches. N Eng J Med 1978; 299: 863–70. Cho YW, Aviado DM. Clinical pharmacology for pediatricians. II. Antisickling agents, with special reference to new vasoerythroactive drugs. J Clin Pharmacol 1982; 22: 1–13. Ueno H, Bai Y, Manning J. Covalent chemical modifiers of sickle cell haemoglobin. Ann N Y Acad Sci 1989; 565: 239–46. Gini EK, Sonnet J. Use of piracctam improves sickle cell deformability in vitro and in vivo. J Clin Pathol 1987; 40: 99–102. Benjamin LJ. Membrane modifiers in sickle cell disease. Ann N Y Acad Sci 1989; 247–61. Editorial: Blood transfusion and allograft survival. Lancet 1984; 1; 830–1. Taylor MB, Whitwam JG. The current status of pulse oximetry: clinical value of continuous noninvasive oxygen saturation monitoring. Anaesthesia 1986; 41: 943–9. Dundee JW, Hassard TH. The influence of haemoglobin and urea levels on the induction dose of thiopentone. Anaesthesia 1983; 38: 26–8. Christensen JH, Andreasen F, Jansen J. Pharmacokinctics and pharmacodynamics of thiopental in patients undergoing renal transplantation. Acta Anaesthesiol Scand 1983; 27: 513–8. Eger IIEI. The pharmacology of isoflurane. Br J Anaesth 1984; 56:71S-99S. Bailey PL, Stanley TH. Pharmacology of intravenous narcotic anaesthetics. In: Miller RD (Ed.) Anesthesia 2nd ed., New York: Churchill Livingstone, 1986: 745–97. Durant NN, Katz RL. Suxamethonium. Br J Anaesth 1982; 54: 195–208. Miller RD, Matteo RS, Benet LZ, Sohn YJ. The pharmacokinetics of d-tubocurarine in man with and without renal failure. J Pharmacol Exp Ther 1977; 202: 1–6. Somogyi AA, Shanks CA, Triggs EJ. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide. Eur J Clin Pharmacol 1977; 12: 23–9. Ramzan MI, Shanks CA, Triggs EJ. Gallamine disposition in surgical with chronic renal failure. Br J Pharmacol 1981; 12: 141–7. Brotherton WP, Matteo RS. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure. Anesthesiology 1981; 55: 273–6. Hunter JM, Jones RS, Utting JE. Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 1984; 56: 941–51. Fahey MR, Morris RB, Miller RD, Nguyen T-L, Upton RA. Pharmacokinetics of Org NC45 (Norcuron) in patients with and without renal failure. Br J Anaesth 1981; 1049–53. Bevan DR, Donati F, Gyasi H, Williams A. Vecuronium in renal failure. Can Anaesth Soc J 1984; 31: 491–6. Starsnic MA, Goldberg ME, Ritter DE, Marr AT, Sosis M, Larijani GE. Does vecuronium accumulate in the renal transplant patient? Can J Anaesth 1989; 36: 35–9. Pollard BJ, Doran BRH. Should vecuronium be used in renal failure? (Letter) Can J Anaesth 1989; 36: 602–3. Hunter JM, Jones RS, Utting JE. Use of atracurium in patients with no renal function. Br J Anaesth 1982; 54: 1251–8. Ward S, Beheimer N, Weatherly BC, Simmonds RJ, Dopson TA. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and in patients with renal failure. Br J Anaesth 1987; 59: 697–706. Flynn PJ, Hughes R, Walton B, Jothilingham S. Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia. Br J Anaesth 1983; 55: 135–8S. Parker CJR, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 1988; 61: 531–40. Gramstad L, Gjerlow JA, Hysing ES, Rugstad HE. Interaction of cyclosporin and its solvent cremophor, with atracurium and vecuronium. Studies in the cat. Br J Anaesth 1986; 58: 1149–55. Crosby E, Robblee JA. Cyclosporin-pancuronium interaction in a patient with a renal allograft. Can J Anaesth 1988; 35: 300–2. Wood GG. Cyclosporine-vecuronium interaction (Letter). Can J Anaesth 1989; 36: 358–66. Viby-Mogensen J. Interaction of other drugs with muscle relaxants. Seminars in Anaesthesia 1985; 6: 52. Nunn JF, Payne JP. Hypoxaemia after general anaesthesia. Lancet 1962; 2: 631–2. Canet J, Montserrat R, Vidal F. Early post-operative arterial oxygen desaturation: determining factors and response to oxygen therapy. Anaesth Analg 1989; 69: 207–12. Wierner K. Calcium, magnesium and phosphate. In: Gowen-Lock AH (Ed.). Varley’s Practical Clinical Biochemistry, 6th ed. London: Heinemann 1988; 601–21. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984; 2: 1116–20.